These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 6461238)
21. Clinical correlates in hypertensive patients with left ventricular hypertrophy diagnosed with echocardiography. Cohen A; Hagan AD; Watkins J; Mitas J; Schvartzman M; Mazzoleni A; Cohen IM; Warren SE; Vieweg WV Am J Cardiol; 1981 Feb; 47(2):335-41. PubMed ID: 6110331 [TBL] [Abstract][Full Text] [Related]
22. The effects of antihypertensive therapy on left ventricular mass in elderly patients. Schulman SP; Weiss JL; Becker LC; Gottlieb SO; Woodruff KM; Weisfeldt ML; Gerstenblith G N Engl J Med; 1990 May; 322(19):1350-6. PubMed ID: 2139175 [TBL] [Abstract][Full Text] [Related]
23. Regression of left ventricular hypertrophy in two-kidney, one clip Goldblatt hypertension. Kuwajima I; Kardon MB; Pegram BL; Sesoko S; Frohlich ED Hypertension; 1982; 4(3 Pt 2):113-8. PubMed ID: 6461595 [TBL] [Abstract][Full Text] [Related]
24. Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol. Corea L; Bentivoglio M; Verdecchia P; Provvidenza M; Motolese M Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):365-70. PubMed ID: 6236155 [TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease. Strauer BE Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004 [TBL] [Abstract][Full Text] [Related]
26. Effect on atrial natriuretic peptides of chronic treatment with alpha-methyldopa and hydralazine in spontaneously hypertensive rats. Kohno M; Yasunari K; Murakawa K; Yokokawa K; Horio T; Kurihara N; Takeda T Am J Hypertens; 1990 Feb; 3(2):111-6. PubMed ID: 2137701 [TBL] [Abstract][Full Text] [Related]
27. Effects of nicardipine on left ventricular hemodynamic patterns in systemic hypertension. de Simone G; Costantino G; Soro S; Di Lorenzo L; Moccia D; Buonissimo S; Ferrara LA Am J Hypertens; 1989 Mar; 2(3 Pt 1):139-45. PubMed ID: 2522007 [TBL] [Abstract][Full Text] [Related]
28. Effect of antihypertensive therapy on calcium transport by cardiac sarcoplasmic reticulum of SHRs. Limas CJ; Spier SS Cardiovasc Res; 1980 Dec; 14(12):692-9. PubMed ID: 6455196 [TBL] [Abstract][Full Text] [Related]
29. Nitrendipine vs. captopril in essential hypertension: effects on circadian blood pressure and left ventricular hypertrophy. Machnig T; Henneke KH; Engels G; Pongratz G; Schmalzl M; Gellert J; Bachmann K Cardiology; 1994; 85(2):101-10. PubMed ID: 7954561 [TBL] [Abstract][Full Text] [Related]
30. Regression of left ventricular hypertrophy in patients with essential hypertension: outcome of 12 years antihypertensive treatment. Shigematsu S; Hiramatsu K; Aizawa T; Yamada T; Takasu N; Niwa A; Miyahara Y; Tsujino M; Shimizu Z Cardiology; 1990; 77(4):280-6. PubMed ID: 1981491 [TBL] [Abstract][Full Text] [Related]
31. Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension. Devereux RB; Savage DD; Sachs I; Laragh JH Am J Cardiol; 1983 Jan; 51(1):171-6. PubMed ID: 6217738 [TBL] [Abstract][Full Text] [Related]
32. Echocardiographic studies of regression of left ventricular hypertrophy in hypertension. Fouad-Tarazi FM; Liebson PR Hypertension; 1987 Feb; 9(2 Pt 2):II65-8. PubMed ID: 2948912 [TBL] [Abstract][Full Text] [Related]
33. Assessment of left-ventricular mass and its response to antihypertensive treatment. Rowlands DB; Glover DR; Ireland MA; McLeay RA; Stallard TJ; Watson RD; Littler WA Lancet; 1982 Feb; 1(8270):467-70. PubMed ID: 6121138 [TBL] [Abstract][Full Text] [Related]
34. The development of coronary insufficiency during prolonged treatment of essential hypertension. Kalnins UV; Skarda IJ; Liepinja DJ; Vitols AV Cor Vasa; 1990; 32(1):64-71. PubMed ID: 2140319 [TBL] [Abstract][Full Text] [Related]
35. Disparate effects of methyldopa and clonidine on cardiac mass and haemodynamics in rats. Ishise S; Pegram BL; Frohlich ED Clin Sci (Lond); 1980 Dec; 59 Suppl 6():449s-452s. PubMed ID: 6450019 [TBL] [Abstract][Full Text] [Related]
36. Regression of left ventricular hypertrophy during treatment with antihypertensive agents. Hill LS; Monaghan M; Richardson PJ Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):255S-260S. PubMed ID: 37879 [TBL] [Abstract][Full Text] [Related]
37. [ACE inhibition: mechanisms of cardioprotection in heart hypertrophy]. Motz W; Strauer BE Klin Wochenschr; 1991; 69 Suppl 24():39-43; discussion 43-4. PubMed ID: 1830911 [TBL] [Abstract][Full Text] [Related]
38. [Regression of hypertension-induced left heart enlargement in an endurance athlete treated with verapamil RR]. Lehmann M; Dürr H; Keul J Z Kardiol; 1989 Jul; 78(7):465-8. PubMed ID: 2528244 [TBL] [Abstract][Full Text] [Related]
39. Left ventricular mass changes with nicardipine therapy in essential hypertension. Gosse P; Lacroix P; Roudaut R; Dallocchio M Cardiovasc Drugs Ther; 1989 Aug; 3(4):525-8. PubMed ID: 2535100 [TBL] [Abstract][Full Text] [Related]
40. [Changes in left ventricular function and structure in hypertensive patients treated with methyldopa and urapidil]. Rakić D; Rumboldt Z; Polić S; Obad M; Bagatin J Lijec Vjesn; 1990; 112(3-4):89-94. PubMed ID: 2204776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]